DISCOVER YOUR NEXT BREAKTHROUGH

Deep Expertise. Customized Solutions.

Discover the next generation of breakthrough CNS therapies with an experienced preclinical CRO. With superior science, creativity, and the know-how to identify promise, PsychoGenics’ leading scientists are adept at illuminating your program’s best candidate.

We apply decades of early-stage drug development experience and a fully customized approach to hone in on the right therapy for your indication of interest. With industry-leading disease models and advanced analytics, we quantify your product’s potential and highlight your best path forward.

The Proven Power of Experience

Combine our expertise with yours to discover your next breakthrough.

20+
years of experience

hands-shaking

400+
client relationships with >70% of clients returning

graduation-cap

20%+
team members with a Ph.D.

molecule

30+
disease models

mouse

50+
behavioral assays

Key Therapeutic Areas

PsychoGenics has extensive experience in a broad range of early-stage drug discovery areas. Our preclinical testing services and industry-leading models cover a broad range of therapeutic areas, enabling a customized approach that fits your specific needs across the therapeutic spectrum.

Our Technologies and Capabilities

PsychoGenics conducts pioneering early preclinical research, with unsurpassed services ranging from sectioning to microdialysis to EEG. With our proprietary suite of automated Cube platforms, we combine machine learning, computer vision, and proprietary bioinformatics to spark the phenotypic discovery of your breakthrough. From the many to the few, we help you spotlight the right compound and highlight your best path for advancement at PsychoGenics.

Science and technology are tightly intertwined, and we use sophisticated tools and methodologies that deliver the industry’s highest quality data.

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started